This study aimed to demonstrate nitric oxide production by human spermatozo
a and to characterize the interaction between nitric oxide and cAMP-related
pathway in the control of human sperm capacitation and protein tyrosine ph
osphorylation. Spermatozoa were incubated in Tyrode's medium with or withou
t bovine serum albumin (BSA), and nitric oxide was measured with the spin t
rap sodium N-methyl-D-glucamine dithiocarbamate. Under noncapacitating cond
itions, spermatozoa produced low levels of nitric oxide. However, under cap
acitating conditions, prominent nitric oxide adduct signals were obtained a
nd a time-dependent increase of nitric oxide production was observed. When
spermatozoa were incubated in Tyrode+BSA medium with nitric oxide-releasing
compounds, intracellular cAMP concentrations increased to levels higher th
an those of spermatozoa incubated in Tyrode + BSA alone. In contrast, incub
ation with nitric oxide synthase inhibitors (N-G-nitro-L-arginine methyl es
ter or N-G-monomethyl L-arginine) decreased intracellular sperm cAMP concen
trations. The inhibitory effect observed with N-G-nitro-L-arginine methyl e
ster on capacitation and tyrosine phosphorylation of two sperm proteins (10
5, 81 kDa) was overcome by the presence of cAMP analogs or of a phosphodies
terase inhibitor. These results indicate that nitric oxide is produced by c
apacitating human spermatozoa and that it may act as a cellular messenger b
y modulating the cAMP pathway involved in capacitation and protein tyrosine
phosphorylation. (C) 2000 Elsevier Science Inc.